Rapid Dose Therapeutics Corp. (CSE: DOSE)
Canada
· Delayed Price · Currency is CAD 0.150
0.00 (0.00%)
Sep 24, 2024, 9:30 AM EDT
Rapid Dose Therapeutics Cash Flow Statement
Financials in millions CAD. Fiscal year is March - February.
Millions CAD. Fiscal year is Mar - Feb.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | May '24 May 31, 2024 | Feb '24 Feb 29, 2024 | Feb '23 Feb 28, 2023 | Feb '22 Feb 28, 2022 | Feb '21 Feb 28, 2021 | Feb '20 Feb 29, 2020 | 2019 - 2018 |
| Net Income | -5 | -4.31 | -3.81 | -8.49 | -1.81 | -7.96 | Upgrade
|
| Depreciation & Amortization | 0.56 | 0.62 | 0.63 | 0.77 | 0.68 | 0.48 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | - | - | -0.09 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | 4.08 | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | - | - | - | 0.57 | Upgrade
|
| Stock-Based Compensation | 0.59 | 0.16 | 0.71 | 1.7 | - | 2.64 | Upgrade
|
| Provision & Write-off of Bad Debts | -0.01 | -0.01 | 0.02 | - | - | - | Upgrade
|
| Other Operating Activities | 0.96 | 0.75 | 0.13 | 0.15 | 0.07 | - | Upgrade
|
| Change in Accounts Receivable | -0.12 | -0.07 | 0.02 | 0.2 | -0.14 | 0.18 | Upgrade
|
| Change in Inventory | 0.03 | 0.01 | 0.08 | -0.04 | -0.19 | -0.07 | Upgrade
|
| Change in Accounts Payable | 0.33 | 0.62 | 1.31 | -0.47 | 0.45 | 0.6 | Upgrade
|
| Change in Unearned Revenue | -0.01 | -0.01 | -0.01 | -0.88 | -0.63 | 0.53 | Upgrade
|
| Change in Other Net Operating Assets | -0.11 | -0.06 | 0.06 | -0.02 | -0.05 | 0.09 | Upgrade
|
| Operating Cash Flow | -2.78 | -2.29 | -0.86 | -3 | -1.62 | -3.03 | Upgrade
|
| Capital Expenditures | - | - | - | -0.04 | -0.01 | -1.22 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | - | 0 | - | - | Upgrade
|
| Cash Acquisitions | - | - | - | 1.89 | - | - | Upgrade
|
| Investment in Securities | - | - | - | - | - | 1.65 | Upgrade
|
| Other Investing Activities | - | - | - | - | - | 0.1 | Upgrade
|
| Investing Cash Flow | - | - | - | 1.85 | -0.01 | 0.53 | Upgrade
|
| Short-Term Debt Issued | - | 0.43 | 0.81 | 0.13 | 1.1 | 0.13 | Upgrade
|
| Long-Term Debt Issued | - | 1.83 | 0.2 | - | - | - | Upgrade
|
| Total Debt Issued | 2.06 | 2.26 | 1.01 | 0.13 | 1.1 | 0.13 | Upgrade
|
| Short-Term Debt Repaid | - | -0.7 | - | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -0.34 | -0.31 | -0.29 | -0.26 | -0.24 | Upgrade
|
| Total Debt Repaid | -0.98 | -1.04 | -0.31 | -0.29 | -0.26 | -0.24 | Upgrade
|
| Net Debt Issued (Repaid) | 1.08 | 1.22 | 0.7 | -0.16 | 0.84 | -0.11 | Upgrade
|
| Issuance of Common Stock | 1.88 | 1.3 | 0.15 | 1.28 | 0.9 | 1.4 | Upgrade
|
| Other Financing Activities | -0.09 | -0.09 | - | - | -0.09 | -0.04 | Upgrade
|
| Financing Cash Flow | 2.86 | 2.43 | 0.86 | 1.13 | 1.65 | 1.24 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | - | 0 | -0.02 | 0.05 | -0 | Upgrade
|
| Net Cash Flow | 0.08 | 0.13 | -0.01 | -0.04 | 0.07 | -1.26 | Upgrade
|
| Free Cash Flow | -2.78 | -2.29 | -0.86 | -3.04 | -1.63 | -4.26 | Upgrade
|
| Free Cash Flow Margin | -236.25% | -224.91% | -120.27% | -173.52% | -216.20% | -4193.31% | Upgrade
|
| Free Cash Flow Per Share | -0.03 | -0.02 | -0.01 | -0.03 | -0.02 | -0.06 | Upgrade
|
| Cash Interest Paid | 0.22 | 0.17 | 0.08 | 0.07 | 0.14 | 0.11 | Upgrade
|
| Levered Free Cash Flow | -2.84 | -1.88 | 0.55 | -1.55 | -1.11 | -1.53 | Upgrade
|
| Unlevered Free Cash Flow | -2.29 | -1.47 | 0.72 | -1.47 | -1.02 | -1.47 | Upgrade
|
| Change in Net Working Capital | 1.22 | 0.33 | -1.6 | 1.2 | 0.67 | -1.33 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.